{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:25:33Z","timestamp":1782761133140,"version":"3.54.5"},"reference-count":29,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"INSTITUTO DE SALUD CARLOS III","doi-asserted-by":"publisher","award":["PT20CIII\/00009"],"award-info":[{"award-number":["PT20CIII\/00009"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pathogenic hemizygous or heterozygous mutations in the IQSEC2 gene cause X-linked intellectual developmental disorder-1 (XLID1), characterized by a variable phenotype including developmental delay, intellectual disability, epilepsy, hypotonia, autism, microcephaly and stereotypies. It affects both males and females typically through loss of function in males and haploinsufficiency in heterozygous females. Females are generally less affected than males. Two novel unrelated cases, one male and one female, with de novo IQSEC2 variants were detected by trio-based whole exome sequencing. The female case had a previously undescribed frameshift mutation (NM_001111125:c.3300dup; p.Met1101Tyrfs*5), and the male showed an intronic variant in intron 6, with a previously unknown effect (NM_001111125:c.2459+21C&gt;T). IQSEC2 gene expression study revealed that this intronic variant created an alternative donor splicing site and an aberrant product, with the inclusion of 19bp, confirming the pathogenic effect of the intron variant. Moreover, a strong reduction in the expression of the long, but also the short IQSEC2 isoforms, was detected in the male correlating with a more severe phenotype, while the female case showed no decreased expression of the short isoform, and milder effects of the disease. This suggests that the abnormal expression levels of the different IQSEC2 transcripts could be implicated in the severity of disease manifestations.<\/jats:p>","DOI":"10.3390\/ijms23169480","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T21:30:34Z","timestamp":1661203834000},"page":"9480","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Differences in Expression of IQSEC2 Transcript Isoforms in Male and Female Cases with Loss of Function Variants and Neurodevelopmental Disorder"],"prefix":"10.3390","volume":"23","author":[{"given":"Beatriz","family":"Baladron","sequence":"first","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia M.","family":"Mielu","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3212-1424","authenticated-orcid":false,"given":"Estrella","family":"L\u00f3pez-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5990-7040","authenticated-orcid":false,"given":"Maria J.","family":"Barrero","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Lopez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose I.","family":"Alvarado","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Monz\u00f3n","sequence":"additional","affiliation":[{"name":"Bioinformatics Unit, Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarai","family":"Varona","sequence":"additional","affiliation":[{"name":"Bioinformatics Unit, Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Cuesta","sequence":"additional","affiliation":[{"name":"Bioinformatics Unit, Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Cazorla","sequence":"additional","affiliation":[{"name":"Neuropediatrics Service, Hospital Puerta de Hierro, 28222 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Lara","sequence":"additional","affiliation":[{"name":"Neuropediatrics Service, Hospital Puerta de Hierro, 28222 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Iglesias","sequence":"additional","affiliation":[{"name":"Neuropediatrics Service, Hospital Puerta de Hierro, 28222 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enriqueta","family":"Rom\u00e1n","sequence":"additional","affiliation":[{"name":"Neuropediatrics Service, Hospital Puerta de Hierro, 28222 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purificaci\u00f3n","family":"Ros","sequence":"additional","affiliation":[{"name":"Neuropediatrics Service, Hospital Puerta de Hierro, 28222 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Gomez-Mariano","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Cubillo","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4135-860X","authenticated-orcid":false,"given":"Esther Hernandez-San","family":"Miguel","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rivera","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6287-8391","authenticated-orcid":false,"given":"Javier","family":"Alonso","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), U758, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7282-2714","authenticated-orcid":false,"given":"Eva","family":"Bermejo-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8372-4180","authenticated-orcid":false,"given":"Manuel","family":"Posada","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6834-350X","authenticated-orcid":false,"given":"Beatriz","family":"Mart\u00ednez-Delgado","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), U758, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Levy, N.S., Umanah, G.K.E., Rogers, E.J., Jada, R., Lache, O., and Levy, A.P. (2019). IQSEC2-Associated Intellectual Disability and Autism. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20123038"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/sgtp.1.2.13285","article-title":"Subtle functional defects in the Arf-specific guanine nucleotide exchange factor IQSEC2 cause non-syndromic X-linked intellectual disability","volume":"1","author":"Shoubridge","year":"2010","journal-title":"Small GTPases"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1038\/s41436-018-0327-7","article-title":"Correction: IQSEC2-related en-cephalopathy in males and females: A comparative study including 37 novel patients","volume":"21","author":"Mignot","year":"2019","journal-title":"Genet. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1111\/epi.13560","article-title":"The molecular and phenotypic spectrum of IQSEC2-related epilepsy","volume":"57","author":"Zerem","year":"2016","journal-title":"Epilepsia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.367","article-title":"A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation","volume":"41","author":"Tarpey","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/humu.23670","article-title":"IQSEC2 mutation update and review of the female-specific phenotype spectrum including intellectual disability and epilepsy","volume":"40","author":"Shoubridge","year":"2019","journal-title":"Hum. Mutat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ejhg.2013.113","article-title":"Expanding the phenotype of IQSEC2 mutations: Truncating mutations in severe intellectual disability","volume":"22","author":"Willems","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","author":"Abecasis","year":"2012","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature24265","article-title":"Landscape of X chromosome inactivation across human tissues","volume":"550","author":"Tukiainen","year":"2017","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neures.2007.10.013","article-title":"IQ-ArfGEF\/BRAG1 is a guanine nucleotide exchange factor for Arf6 that interacts with PSD-95 at postsynaptic density of excitatory synapses","volume":"60","author":"Sakagami","year":"2008","journal-title":"Neurosci. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/cge.13507","article-title":"Deep phenotyping of 14 new patients with IQSEC2 variants, including monozygotic twins of discordant phenotype","volume":"95","author":"Radley","year":"2019","journal-title":"Clin. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1600-0854.2007.00634.x","article-title":"Regulation of Arf activation: The Sec7 family of guanine nucleotide exchange factors","volume":"8","author":"Casanova","year":"2007","journal-title":"Traffic"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainres.2008.11.061","article-title":"The postsynaptic density protein, IQ-ArfGEF\/BRAG1, can interact with IRSp53 through its proline-rich sequence","volume":"1251","author":"Sanda","year":"2009","journal-title":"Brain Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Mart\u00edn, E., Mart\u00ednez-Delgado, B., Bermejo-S\u00e1nchez, E., Alonso, J., and Posada, M. (2018). SpainUDP: The Spanish Undiag-nosed Rare Diseases Program. Int. J. Environ. Res. Public Health, 15.","DOI":"10.20944\/preprints201806.0216.v1"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ymgme.2015.11.003","article-title":"Undiagnosed Diseases Network International (UDNI): White paper for global actions to meet patient needs","volume":"116","author":"Taruscio","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ejhg.2015.267","article-title":"A novel splicing mutation in the IQSEC2 gene that modulates the phenotype severity in a family with intellectual disability","volume":"24","author":"Madrigal","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/cge.13908","article-title":"IQSEC2 disorder: A new disease entity or a Rett spectrum continuum?","volume":"99","author":"Lopergolo","year":"2021","journal-title":"Clin. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ng.588","article-title":"Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic intellectual disability","volume":"42","author":"Shoubridge","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10897-013-9671-6","article-title":"Diagnostic exome sequencing identifies two novel IQSEC2 mutations associated with X-linked in-tellectual disability with seizures: Implications for genetic counseling and clinical diagnosis","volume":"23","author":"Gandomi","year":"2014","journal-title":"J. Genet. Couns."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1002\/ajmg.a.38404","article-title":"The role of IQSEC2 in syndromic intellectual disability: Nar-rowing the diagnostic odyssey","volume":"173","author":"Helm","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/ejhg.2015.5","article-title":"Next-generation sequencing in X-linked intellectual disability","volume":"23","author":"Tzschach","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e1181700","DOI":"10.1080\/21592799.2016.1181700","article-title":"Allosteric properties of PH domains in Arf regulatory proteins","volume":"6","author":"Roy","year":"2016","journal-title":"Cell. Logist."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature03479","article-title":"X-inactivation profile reveals extensive variability in X-linked gene expression in females","volume":"434","author":"Carrel","year":"2005","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/hmg\/ddu564","article-title":"Landscape of DNA methylation on the X chromosome reflects CpG density, functional chromatin state and X-chromosome inactivation","volume":"24","author":"Cotton","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ejhg.2015.123","article-title":"Xp11.2 microduplications including IQSEC2, TSPYL2 and KDM5C genes in patients with neurodevelopmental disorders","volume":"24","author":"Moey","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1093\/nar\/gkr1257","article-title":"A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian diseases","volume":"40","author":"Li","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1186\/gb-2007-8-2-r24","article-title":"Quantifying similarity between motifs","volume":"8","author":"Gupta","year":"2007","journal-title":"Genome Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"W39","DOI":"10.1093\/nar\/gkv416","article-title":"The MEME Suite","volume":"43","author":"Bailey","year":"2015","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/16\/9480\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:13:46Z","timestamp":1760141626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/16\/9480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":29,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23169480"],"URL":"https:\/\/doi.org\/10.3390\/ijms23169480","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]}}}